Conditions: Esophageal Cancer Gastric Cancer
Keywords: esophageal cancer gastroesophageal cancer gastric cancer
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 60
Healthy volunteers: no

Brief summary:
Cetuximab, Paclitaxel, Carboplatin and Radiation for Esophageal, Gastroesophageal Junction and Gastric Cancer

Detailed description:
The primary objective of this phase II trial is to estimate the rate of complete pathologic response as determined by surgical resection or post treatment endoscopy (for patients not undergoing resection) for the treatment regimen being tested. With a total accrual of 28 evaluable patients.

Arms:
arm 1: Cetuximab, paclitaxel, and carboplatin weekly for 6 weeks with 50.4 Gy radiation.

Interventions: intervention 1: Cetuximab,Paclitaxel, Carboplatin
Intervention descriptions: intervention 1: IV treatment for 6 weeks

Protocol document:
Prot_SAP_ICF_000.pdf: